This article was originally published in The Gray Sheet
Insertable loop recorder is useful for long-term monitoring and diagnosis of patients with unexplained, recurrent and infrequent syncope, suggests a study by Andrew Krahn, MD, University of Western Ontario, et al., presented March 31 at ACC. The 85-patient study found that during a mean 2.9 months (1 0.9 months) of follow-up, 82 episodes of syncope, pre-syncope or dizziness occurred in 45 (53%) of patients. The Reveal-recorded episodes assisted diagnosis of the syncope as bradycardia, tachycardia, multiple arrhythmias, and sinus rhythm. Reveal received 510(k) clearance in February ("The Gray Sheet" Feb. 9, I&W-6)...
You may also be interested in...
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.
US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.